Cochrane Abstracts
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risk of Thromboembolism in Patients With COVID‐19 Who Are Using Hormonal Contraception." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433318/all/Risk_of_thromboembolism_in_patients_with_COVID‐19_who_are_using_hormonal_contraception.
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433318/all/Risk_of_thromboembolism_in_patients_with_COVID‐19_who_are_using_hormonal_contraception. Accessed January 21, 2025.
Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433318/all/Risk_of_thromboembolism_in_patients_with_COVID‐19_who_are_using_hormonal_contraception
Risk of Thromboembolism in Patients With COVID‐19 Who Are Using Hormonal Contraception [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433318/all/Risk_of_thromboembolism_in_patients_with_COVID‐19_who_are_using_hormonal_contraception.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
ID - 433318
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433318/all/Risk_of_thromboembolism_in_patients_with_COVID‐19_who_are_using_hormonal_contraception
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
